De Yong Wen
Chief Executive Officer en SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. .
Fortuna: 639 338 $ al 29/02/2024
Perfil
Currently, De Yong Wen is Co-Chief Executive Officer & Executive Director for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
and Chairman-Supervisory Board of China National Accord Medicines Corp.
Ltd.
Mr. Wen is also on the board of Sinopharm Group Co., Ltd., China National Medicines Co., Ltd., Sinopharm Industrial Investment Co., Ltd.
and Shanghai Henlius Biotech, Inc.
De Yong Wen received an undergraduate degree from West China University of Medical Sciences and an MBA from Donghua University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
13/12/2022 | 187 100 ( 9.50% ) | 639 338 $ | 29/02/2024 |
Cargos activos de De Yong Wen
Empresas | Cargo | Inicio |
---|---|---|
SINOPHARM GROUP CO. LTD. | Director/Board Member | 01/09/2017 |
CHINA NATIONAL MEDICINES CORPORATION LTD. | Director/Board Member | 09/05/2019 |
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Chief Executive Officer | 01/06/2022 |
SHANGHAI HENLIUS BIOTECH, INC. | Director/Board Member | 28/07/2022 |
CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Chairman | 10/07/2019 |
Sinopharm Industrial Investment Co., Ltd.
Sinopharm Industrial Investment Co., Ltd. Financial ConglomeratesFinance Sinopharm Industrial Investment Co., Ltd. engages in the provision of industrial investment services. Its business activities include management of pharmaceutical business, asset restructuring and investment advisory services. The company was founded on May 6, 2008 and is headquartered in Shanghai, China. | Director/Board Member | 20/01/2020 |
Antiguos cargos conocidos de De Yong Wen.
Empresas | Cargo | Fin |
---|---|---|
Chongqing Yao Pharmaceutical Co., Ltd.
Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China. | Director/Board Member | - |
C.Q. PHARMACEUTICAL HOLDING CO., LTD. | Director/Board Member | - |
Formación de De Yong Wen.
Donghua University | Masters Business Admin |
West China University of Medical Sciences | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 6 |
---|---|
SINOPHARM GROUP CO. LTD. | Distribution Services |
CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD. | Health Technology |
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. | Health Technology |
CHINA NATIONAL MEDICINES CORPORATION LTD. | Health Technology |
C.Q. PHARMACEUTICAL HOLDING CO., LTD. | Health Technology |
SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Sinopharm Industrial Investment Co., Ltd.
Sinopharm Industrial Investment Co., Ltd. Financial ConglomeratesFinance Sinopharm Industrial Investment Co., Ltd. engages in the provision of industrial investment services. Its business activities include management of pharmaceutical business, asset restructuring and investment advisory services. The company was founded on May 6, 2008 and is headquartered in Shanghai, China. | Finance |
Chongqing Yao Pharmaceutical Co., Ltd.
Chongqing Yao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Yao Pharmaceutical Co., Ltd. engages in pharmaceutical manufacture, It integrates with research and development, manufacturing, marketing, and sales of medicines. The company was founded on July 21, 1997 and is headquartered in Chongqing, China. | Health Technology |